Stopping mineralocorticoid receptor antagonists after hyperkalemia: trial emulation in data from routine care

ConclusionsStopping MRA after an episode of hyperkalemia was associated with reduced risk for recurrent hyperkalemia, but higher risk of death or cardiovascular events. Recurrent hyperkalemia was common in either strategy.

Source: European Journal of Heart Failure - July 1, 2021 Category: Cardiology Authors: Marco Trevisan, Biostat Edouard L. Fu, Yang Xu, Gianluigi Savarese, Friedo W Dekker, Lars H Lund, Catherine M Clase, Arvid Sj ölander Biostat, Juan Jesus Carrero Tags: Research Article Source Type: research